Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 12, 2002
[SEN virus--novel hepatotropic agent causing hepatitis?]Dariusz Marek LebensztejnPolski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 6, 2003
[Contemporary opinions on liver fibrosis pathogenesis]Dariusz Marek LebensztejnPrzeglad Epidemiologiczny|September 30, 2005
[Reversibility of advanced liver fibrosis--therapeutic possibility and biochemical monitoring of the disease]Dariusz Marek LebensztejnClinical and Experimental Hepatology|May 24, 2021
Non-alcoholic fatty liver disease and lipotoxicityNatalia Wasilewska, Dariusz Marek LebensztejnPolski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|July 21, 2010
[Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease]Anna Romanowska, Dariusz Marek LebensztejnApplied Spectroscopy|July 12, 2015
Near-Infrared (NIR) Spectroscopy of Synthetic Hydroxyapatites and Human Dental TissuesJoanna Kolmas, Dariusz Marek, Waclaw KolodziejskiClinical and Experimental Hepatology|March 28, 2019
Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in childrenMarta Flisiak-Jackiewicz, Dariusz Marek LebensztejnWorld Journal of Gastroenterology|March 8, 2006
Ultrastructure of Kupffer cells and hepatocytes in the Dubin-Johnson syndrome: a case reportMaria Elzbieta Sobaniec-Lotowska, Dariusz Marek LebensztejnWorld Journal of Gastroenterology|January 27, 2006
Histological outcome of chronic hepatitis B in children treated with interferon alphaSobaniec-Lotowska Maria Elzbieta, Lebensztejn Dariusz MarekBiomedicines|March 25, 2022
Chemerin as Potential Biomarker in Pediatric Diseases: A PRISMA-Compliant StudyKatarzyna Zdanowicz, Anna Bobrus-Chociej, Dariusz Marek LebensztejnPageof 6